SOD2 and breast cancer: In aggressive breast cancer subtypes, the enhanced expression of MnSOD was strongly correlated with an increase in AMPK activation, as assessed by both the phosphorylation on the active site (Thr172) and phosphorylation of the downstream target, acetyl CoA carboxylase.